glp-1 drugs and high blood pressure Agonists Pressure: A Review of the Evidence | Current Hypertension Reports GLP-1 drugs tied to blood
Description
Combination Approaches Future treatments might combine incretin agonists with other weight loss mechanisms like metabolism boosters, appetite suppressants working through non-incretin pathways, or fat absorption inhibitors

Liu L, Shi H, Shi Y, Wang A, Guo N, Tao H, et al
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
We therefore suggest future studies to more thoroughly report maternal and treatment characteristics including trimester of exposure

Disclosures: G

Stopping the medication may resolve neurochemical sexual side effects but reintroduce the psychological barriers to desire that existed before treatment

Reference List Clinical GI side effect background
